Recent Activity

Loading...

ARKG

ARK Genomic Revolution ETF · BATS

  • Category Equity
  • Expense Ratio 0.75%
  • Listing Date Oct 31, 2014
  • Volume 2,457,320.0
  • Market Cap (AUM) $1,460.48M

Performance

+5.74%

1W

+10.04%

1M

-15.51%

3M

+1.92%

6M

-19.14%

YTD

-12.38%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Twist Bioscience Corp.TWST8.48%
  • CRISPR Therapeutics AGCRSP6.59%
  • Recursion Pharmaceuticals, Inc. Class ARXRX5.92%
  • CareDx, Inc.CDNA5.81%
  • Intellia Therapeutics, Inc.NTLA4.34%
  • Schrodinger, Inc.SDGR3.86%
  • Arcturus Therapeutics Holdings, Inc.ARCT3.60%
  • Ionis Pharmaceuticals, Inc.IONS3.53%
  • Moderna, Inc.MRNA3.47%
  • Beam Therapeutics, Inc.BEAM3.42%

Technical Analysis of ARKG 2024-05-10

Overview:

In analyzing the technical indicators for ARKG over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...

See more ...

Recent News & Updates